Quantcast

Latest pharmaceutical industry Stories

2014-07-18 20:21:37

CHAPEL HILL, N.C., July 18, 2014 /PRNewswire/ -- Patient engagement is a critical success factor in pharmaceutical marketing today. Although marketing is one of the principal groups that handle patient engagement activities, Government Affairs and Public Policy groups within the pharmaceutical industry are among the functions that are becoming increasingly involved in activities and initiatives to positively impact the "patient journey." Recent research by benchmarking firm, Best Practices,...

2014-07-18 16:23:22

TARRYTOWN, N.Y., July 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2014 financial and operating results on Tuesday, August 5, 2014, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International). A link to the...

2014-07-18 16:21:29

MINNEAPOLIS, MN, July 18, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA), an industrial biotechnology company producing renewable chemicals, announced today that it will report its financial results for the second quarter 2014 on Thursday August 7, 2014. BioAmber will also hold a live investor conference call and webcast at 4:30 PM Eastern Time (1:30 PM PT) to discuss the results. Conference Call and Webcast Thursday, August 7, 2014 @ 4:30 PM Eastern Time / 1:30 PM Pacific Time...

2014-07-18 08:24:51

BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer. MCNA U.S. Regulatory Update Following several months of active dialogue with the U.S. Food and Drug Administration (FDA),...

2014-07-18 08:24:41

BUENA, N.J., July 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:15 pm ET on Thursday, July 24, 2014 to discuss the 2nd quarter 2014 results. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO The Company invites you to listen to the call by dialing 1-877-870-4263. International participants should call 1-412-317-0790. Canadian...

2014-07-17 23:05:29

Required Change Reflects Reports of Additional Clotting Not Related to Condition Covered by Current Warnings DALLAS (PRWEB) July 17, 2014 The U.S. Food & Drug Administration (FDA) has ordered testosterone therapy drug makers to provide additional warnings in regard to blood clots to those already in place, the national law firm of Baron and Budd reports. This development occurs as federal litigation involving testosterone treatment lawsuits proceed in the U.S. District Court, Northern...

2014-07-17 12:30:57

New Manhattan Research Study from Decision Resources Group Helps Marketers Understand How Physicians Are Using Multichannel Information and Services from Pharma BURLINGTON, Mass., July 17, 2014 /PRNewswire/ -- Decision Resources Group's new Manhattan Research study, ePharma Physician(®) 2014, indicates that physicians are looking to pharmaceutical companies to help them keep patients engaged in their healthcare by providing patient services. The study shows strong physician interest in...

2014-07-17 12:30:54

BRISBANE, Calif., July 17, 2014 /PRNewswire/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that pirfenidone has been granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). This designation is reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant...

2014-07-17 08:29:32

BOSTON, July 17, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it has expanded its intellectual property portfolio following the receipt of a patent covering bioadhesive progressive hydration tablets. The issued patent, U.S. Patent 8,765,177, pertains to a...

2014-07-17 08:28:49

MUMBAI, July 17, 2014 /PRNewswire/ -- - The Facility Will be Situated in Monroe, North Carolina, USA - It Will Manufacture Oral Solids, Injectables and Topicals Over a Five Year Period Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the US. The company plans to set up this manufacturing facility at Monroe Corporate Center, North Carolina, USA. The facility will be spread...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related